Recruiting

Clobetasol Propionate

Sponsor:

Callender Center for Clinical Research

Code:

NCT01111981

Conditions

Alopecia

Eligibility Criteria

Sex: Female

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Clobetasol Propionate 0.05% Emollient Foam

Study Details

Brief summary:

The purpose of this study is to ascertain the safety and efficacy of

Clobetasol Propionate 0.05% E Foam in the treatment of Central Centrifugal

Cicatricial Alopecia.

Conditions

Alopecia

Study ID

NCT01111981

Start date

Oct, 2009

Status verified date

Apr, 2010

Completion date

Oct, 2010

Anticipated

Primary completion date

Feb, 2010

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: Female

Age: 18 - 70+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Patients with CCCA, treated or untreated
  • Score 0 - 1 on Scale/Questionnaire
  • 18 years of age or older
  • Women of African descent

Exclusion Criteria:

  • Score > 1 on Scale/Questionnaire
  • Alopecias other than CCCA, including alopecia arreata, lichen planopilaris, trichotillomania, and traction alopecia
  • History of hair transplantation
  • Children less than 18 years of age
  • Males
  • Women of non-African descent
  • Pregnancy or breastfeeding. Women of childbearing age must use reliable forms of contraception (e.g., abstinence, oral contraceptives, or spermicide and condoms)
  • Anti-dandruff shampoo within 30 days
  • Anti-inflammatory medications such as antibiotics (doxycycline, minocycline, rifampin, etc.), steroids (oral prednisone, topical corticosteroids,etc.), NSAIDs (ibuprofen, aspirin, etc.)

Study Design

Enrollment

30 participants

Anticipated

Intervention Model

Single group

Primary purpose

Treatment

Interventions and Outcome Measures

Interventions

Clobetasol Propionate 0.05% Emollient Foam

Clobetasol Propionate 0.05% E Foam to be applied to affected area once a day for 16 weeks

Primary outcome measure

  • Improvement of pruritis, tenderness, and pain [ Time Frame: 4 months ]

Central Contacts and Locations

Central contacts

Lynn Carter, BA

301-249-0970clinresearch@callenderskin.com

Cherie Young, M.D.

301-249-0970clinresearch@callenderskin.com

Locations

Callender Center for Clinical Research

Recruiting

Mitchellville, Maryland, United States, 20721

Contacts

Lynn Carter, BA

301-249-0970clinresearch@callenderskin.com

Niccole Mathews

301-249-0970clinresearch@callenderskin.com

More Information

Sponsor

Callender Center for Clinical Research

Last update posted

Apr 28, 2010

Last verified

Apr, 2010

Keywords

  • alopecia
  • CCCA - Central Centrifugal Cicatricial Alopecia

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Callender Center for Clinical Research on 2010-04-28.